Is association between thyroid hormones and gut peptides, ghrelin and obestatin, able to suggest new regulatory relation between the HPT axis and gut?

Regulatory Peptides

Volumn 189, Issue , 2014, Pages 17-21

  Emami, Ali ^a   Nazem, Reza ^a   Hedayati, Mehdi ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ghrelin; HPT axis; Hyperthyroidism; Hypothyroidism; Obestatin; Subclinical

Indexed keywords

GHRELIN; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGED; BLOOD; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED;

ADULT; AGED; FEMALE; GHRELIN; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84894100197     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2014.01.001     Document Type: Article

References (38)

1. Chen C.Y., Asakawa A., Fujimiya M., Lee S.D., Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 2009, 61:430-481.
2. Abizaid A., Horvath T.L. Brain circuits regulating energy homeostasis. Regul Pept 2008, 149:3-10.
3. Bluet-Pajot M.T., Tolle V., Zizzari P., Tomasetto C., Grouselle D., Ghrelin Epelbaum J. A striking example of neuroendocrine peptide pleiotropy. Med Sci (Paris) Aug-Sep 2005, 21(8-9):715-721.
4. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature Dec 9, 1999, 402(6762):656-660. [PMID: 10604470].
5. Hassouna R., Zizzari P., Tolle V. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J Neuroendocrinol Jul 2010, 22(7):793-804.
6. Boguszewski C.L., Paz-Filho G., Velloso L.A. Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain. Endokrynol Pol Mar-Apr 2010, 61(2):194-206.
7. Majumdara I.D., Weber H.C. Gastrointestinal regulatory peptides and their effects on fat tissue. Curr Opin Endocrinol Diabetes Obes Feb 2010, 17(1):51-56.
8. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science Nov 11, 2005, 310(5750):996-999.
9. Epelbaum J., Bedjaoui N., Dardennes R., Feng D.D., Gardette R., Grouselle D., Loudes C., Simon A., Tolle V., Yang S.K., Zizzari P. Role of the ghrelin/obestatin balance in the regulation of neuroendocrine circuits controlling body composition and energy homeostasis. Mol Cell Endocrinol Jan 27, 2010, 314(2):244-247.
10. Ren A.J., Guo Z.F., Wang Y.K., Lin L., Zheng X., Yuan W.J. Obestatin, obesity and diabetes. Peptides Feb 2009, 30(2):439-444.
11. Stengel A., Goebel M., Wang L., Taché Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides Feb 2010, 31(2):357-369.
12. Zhang J.V., Jahr H., Luo C.W., Klein C., Van Kolen K., Ver Donck L., De A., Baart E., Li J., Moechars D., Hsueh A.J. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol Jun 2008, 22(6):1464-1475.
13. Germain N., Galusca B., Grouselle D., Frere D., Tolle V., Zizzari P., Lang F., Epelbaum J., Estour B. Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology Apr 2009, 34(3):413-419.
14. Vicennati V., Genghini S., De Iasio R., Pasqui F., Pagotto U., Pasquali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol Sep 2007, 157(3):295-301.
15. Katergari S.A., Milousis A., Pagonopoulou O., Asimakopoulos B., Nikolettos N.K. Ghrelin in pathological conditions. Endocr J Jul 2008, 55(3):439-453.
16. Gunduz M., Gunduz E., Kircelli F., Okur N., Ozkaya M. Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism. Int J Endocrinol 2012, 2012:109797.
17. Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Cobin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., Weissman N.J. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA Jan 14, 2004, 291(2):228-238.
18. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E., Serum T.S.H. T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab Feb 2002, 87(2):489-499.
19. Iglesias P., Díez J.J. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine Nov 2007, 40(2):61-70.
20. Somogyi V., Gyorffy A., Scalise T.J., Kiss D.S., Goszleth G., Bartha T., Frenyo V.L., Zsarnovszky A. Endocrine factors in the hypothalamic regulation of food intake in females: a review of the physiological roles and interactions of ghrelin, leptin, thyroid hormones, oestrogen and insulin. Nutr Res Rev Mar 2011, 22:1-23.
21. Manuchehri A.M., Sathyapalan T., Jayagopal V., Kilpatrick E.S., Ghatei M.A., Bloom S.R., Atkin S.L. Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations. Clin Endocrinol (Oxf) May 2008, 68(5):836-838.
22. Gjedde S., Vestergaard E.T., Gormsen L.C., Riis A.L., Rungby J., Møller N., Weeke J., Jørgensen J.O. Serum ghrelin levels are increased in hypothyroid patients and become normalized by l-thyroxine treatment. J Clin Endocrinol Metab Jun 2008, 93(6):2277-2280.
23. Altinova A.E., Toruner F., Karakoc A., Yetkin I., Ayvaz G., Cakir N., Arslan M. Serum ghrelin levels in patients with Hashimoto's thyroiditis. Thyroid Dec 2006, 16(12):1259-1264.
24. Practical application of the 2010 ATA/AACE: hypo and hyperthyroidism guidelines http://www.whcenter.org/documents/CME/Hyperthyroidism_Guideline_Talk_WHC2010%20FINAL.pdf.
25. AACE thyroid guidelines: endocrine practice vol 8 no. 6 November/December 2002 http://www.aace.com/files/hypo-hyper.pdf.
26. Gharib H., Tuttle R.M., Baskin H.J., Fish L.H., Singer P.A., McDermott M.T. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab Jan 2005, 90(1):581-585. [discussion 586-7].
27. Zhang N., Yuan C., Li Z., Li J., Li X., Li C., Li R., Wang S.R. Meta-analysis of the relationship between obestatin and ghrelin levels and the ghrelin/obestatin ratio with respect to obesity. Am J Med Sci Jan 2011, 341(1):48-55.
28. Reinehr T., de Sousa G., Roth C.L. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf) Feb 2008, 68(2):304-310.
29. Kosowicz J., Baumann-Antczak A., Ruchała M., Gryczyñska M., Gurgul E., Sowiñski J. Thyroid hormones affect plasma ghrelin and obestatin levels. Horm Metab Res Feb 2011, 43(2):121-125.
30. Gurgul E., Ruchała M., Kosowicz J., Zamysłowska H., Wrotkowska E., Moczko J., Sowiński J. Ghrelin and obestatin in thyroid dysfunction. Endokrynol Pol 2012, 63(6):456-462.
31. Giménez-Palop O., Giménez-Pérez G., Mauricio D., Berlanga E., Potau N., Vilardell C., Arroyo J., González-Clemente J.M., Caixàs A. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol Jul 2005, 153(1):73-79.
32. Sadegholvad A., Afkhamizadeh M., Ranjbar-Omrani G. Serum ghrelin changes in thyroid dysfunction. Arch Iran Med Apr 2007, 10(2):168-170.
33. Tanda M.L., Lombardi V., Genovesi M., Ultimieri F., Lai A., Gandolfo M., Dalle Mule I., Grasso L., Bogazzi F., Broglio F., Ghigo E., Martino E., Bartalena L. Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction. J Endocrinol Invest Jan 2009, 32(1):74-78.
34. Sawicka B., Bossowski A., Szalecki M., Wysoka J., Koput A., Zelazowska-Rutkowska B., Tobolczyk J., Rogowski F., Łuba M. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases. J Pediatr Endocrinol Metab Apr 2010, 23(4):345-354.
35. Benso A., Calvi E., Gramaglia E., Olivetti I., Tomelini M., Ghigo E., Broglio F. Other than growth hormone neuroendocrine actions of ghrelin. Endocr Dev 2013, 25:59-68.
36. Bossowski A., Czarnocka B., Harasymczuk J., Moniuszko A., Bardadin K., Lyczkowska A., Hanusek K., Bossowska A. Identification of GPR39 receptor and ghrelin receptor in thyroid tissues in paediatric patients with immune and non-immune thyroid diseases. Horm Res Paediatr 2013, 79:130-136.
37. Kluge M., Riedl S., Uhr M., Schmidt D., Zhang X., Yassouridis A., Steiger A. Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol Jun 2010, 162(6):1059-1065.
38. Karaoglu A., Aydin S., Dagli A.F., Cummings D.E., Ozercan I.H., Canatan H., Ozkan Y. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem Mar 2009, 323(1-2):113-118.